News | Published:

Major UK cancer research charities to consider merger

Naturevolume 409page4 (2001) | Download Citation

Subjects

London

British cancer researchers could find themselves with a major new research organization, loosely modelled on the US National Cancer Institute (NCI), after the country's two main cancer charities meet this month to consider a merger.

Merger pending: the Imperial Cancer Research Fund's London staff could gain closer ties with university researchers. Credit: ICRF

The trustees from the Cancer Research Campaign (CRC) and the Imperial Cancer Research Fund (ICRF) will meet up on 16 January. Even if a full merger is not deemed financially viable, the charities say they will collaborate much more closely in future on basic and clinical research.

“Collaboration is the best way to exploit our resources and reduce our costs,” says Gordon McVie, director general of the CRC. Both charities want to make more use of new equipment and techniques, such as microarray DNA chips and X-ray crystallography, he adds.

The CRC currently concentrates on extramural research, whereas most of the ICRF's work is done intramurally at its main institute in London. Paul Nurse, director general of the ICRF, says that a merger would see both classes of work continue in parallel, as happens at the publicly funded NCI in the United States.

But the UK charities have a long way to go in matching the NCI's financial might: each spends just over £100 million (US$150 million) per year, against the NCI's $4 billion. “We are chronically short of funds,” says McVie. “The British government has abdicated its responsibility to the charities.”

Scientists cautiously welcomed discussion of the merger, which could take at least a year to implement. Peter Hoskin, a CRC-funded oncologist at the Mount Vernon Hospital in Middlesex, says: “It would be better if funding and research were less fragmented.”

Authors

  1. Search for Georgina Kenyon in:

About this article

Publication history

Issue Date

DOI

https://doi.org/10.1038/35051225

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing